These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 15447698)
21. Sumatriptan and naproxen sodium for the acute treatment of migraine. Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Diener HC Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900 [TBL] [Abstract][Full Text] [Related]
23. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Gawel M; Aschoff J; May A; Charlesworth BR; Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607 [TBL] [Abstract][Full Text] [Related]
24. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life. Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178 [TBL] [Abstract][Full Text] [Related]
25. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study). Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ; Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358 [TBL] [Abstract][Full Text] [Related]
26. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [TBL] [Abstract][Full Text] [Related]
28. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine. Láinez MJ; Evers S; Kinge E; Allais G; Allen C; Rao NA; Massaad R; Lis K Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330 [TBL] [Abstract][Full Text] [Related]
29. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Diener HC; Gendolla A; Gebert I; Beneke M Headache; 2005; 45(7):874-82. PubMed ID: 15985104 [TBL] [Abstract][Full Text] [Related]
30. Rizatriptan in the treatment of migraine. Dahlof CG; Rapoport AM; Sheftell FD; Lines CR Clin Ther; 1999 Nov; 21(11):1823-36; discussion 1821. PubMed ID: 10890255 [TBL] [Abstract][Full Text] [Related]
31. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR Headache; 2006; 46(7):1142-50. PubMed ID: 16866718 [TBL] [Abstract][Full Text] [Related]
32. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Winner P; Landy S; Richardson M; Ames M Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449 [TBL] [Abstract][Full Text] [Related]
33. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100 [TBL] [Abstract][Full Text] [Related]
34. Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial. Saper J; Dahlof C; So Y; Tfelt-Hansen P; Malbecq W; Loeys T; Barraclough E; Klipfel M; Lines C; Visser H; Reines S; Yuen E; Headache; 2006 Feb; 46(2):264-75. PubMed ID: 16492236 [TBL] [Abstract][Full Text] [Related]
35. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting. Baos V; Serrano A; Torrecilla M; Bertral C; Caloto MT; Nocea G; Gerth WC; Int J Clin Pract; 2003 Nov; 57(9):761-8. PubMed ID: 14686564 [TBL] [Abstract][Full Text] [Related]
36. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study. Spierings EL; Keywood C Pain Med; 2009; 10(4):633-8. PubMed ID: 19453958 [TBL] [Abstract][Full Text] [Related]
37. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717 [TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
39. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study. Cady R; Martin V; Adelman J; Diamond M; Sajjan S; Hu XH Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699 [TBL] [Abstract][Full Text] [Related]
40. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons. Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]